Pneumonia

last authored: Feb 2010, David LaPierre
last reviewed:

 

 

Introduction

Pneumonia, or infection of the lower respiratory tract, is one of the most important causes of death, especially during adult years. It can be caused by a number of pathogens, including bacteria, viruses, fungi, protozoans, and parasites.

normal lung on left; bronchopneumonia (arrows) on right.

courtesy of Dr Zhaolin Xu, Department of Pathology, Dalhousie University

As it is often readily curable, every health care provider should be on the lookout for it, and every physician should know how to rapidly diagnose and treat pneumonia.

 

 

 

 

 

 

 

 

 

 

 

 

The Case of Henry C

Henry Chu is a...

return to top

 

 

 

Causes and Risk Factors

Risk factors for pneumonia include:

 

  • most common pathogens
  • bacteria
  • viruses

most common pathogens

The following pathogens represent the most common causes of pneumonia in different populations:

 

community-acquired in healthy adults

community-acquired in elderly/
comorbidities/nursing home

nosocomial

HIV-associated

alcoholic

ventilator-associated

  • Pseudomonas
  • Klebsiella
  • Serratia
  • Enterobacter
  • Citrobacter
  • Stenotrophomonas
  • Acinetobacter
  • Burkholderia
  • MRSA

immunocompromised

  • bacterial
  • tuberculosis
  • fungal
  • PJP
  • Nocardia
  • viral
  • toxoplasma, if heart transplant

 

 

bacterial pathogens

Streptococcus pneumoniae (pneumococcus) is the most common cause of community-acquired pneumonia. It colonizes the oropharynx of up to 25% of healthy adults. Increased predisposition is seen in people with alcoholism, chronic lung disease, renal failure, sickle cell disease, prior splenectomy, hematologic malignancy, and HIV infection. Lobar consolidation with air bronchograms is typically seen by the 2nd or 3rd day of illness. In most areas of the world, penicillin G is the treatment of choice, with cephalosporins or vancomycin indicated depending on regional sensitivity patterns.

 

Staphylococcus aureus accounts for 2-5% of community acquired pneumonias, 11% of hospital pneumonias, and up to 26% of pneumonias following viral infection.

 

Haemophilus influenzae, a gram-negative coccobacillus often present in the upper respiratory tract, is especially important in people with COPD. Even though pathologic involvement therefore depends on isolation by bronchoscopy or other methods, if seen in a sputum sample, treatment should begin with ampicillin plus a beta-lactamase inhibitor, or a 2nd- or 3rd-generation cephalosporin.

 

Gram-negative bacilli are increasingly important lung pathogens due to use of potent antibiotics and intensive care units. They are ubiquitious throughout hospitals, contaminating equipment and instruments, and are a major source of nosocomial pneumonia. Important pathogens include klebsiella pneumoniae, Escherichia coli, Pseudomonas spp, Legionella

 

Other bacteria include mycoplasmal and chlamydial pneumonias

  • Francisella tularensis
  • Yersinia pestis
  • Rhodococcus equi

 

viral pathogens

In children, viruses are the most common cause of pneumonia, with respiratory synctial virus being the most common pathogen.

 

Respiratory viral infection is usually limited to the upper respiratory tract, and only a small proportion of infected adults develop pneumonia.

 

Viral causes include:

  • influenza (older adults, patients with chronic heart, lung, or kidney disease, last trimester pregnancy)
  • varicella
  • measles
  • CMV (immunosuppressed patients)
  • hantavirus

Influenza-induced necrosis of epithelial cells predisposes to bacterial colonization, and S. pneumoniae, S. aureus, and H. influenzae pneumonias are the most common concomitant infections.

return to top

 

 

 

Pathophysiology

Under normal circumstances, the lungs are sterile. Pathogens can enter through inhalation, by hematogenous spread, from a contiguous focus of infection, or most commonly by aspiration of oropharyngeal secretions (almost 50% of healthy men aspirate some oropharyngeal contents during sleep). Infection can also follow inhalation of aerosolized droplets, as occurs with tuberculosis.

 

Defenses against pulmonary colonization include cough, mucociliary clearance, and other innate immune defenses. Impaired normal defense mechanisms frequently contribute to the development of pneumonia. These can include:

 

Infection can spread along airways and through alveolar walls, and exudative inflammation results.

 

Lobar Pneumonia:

return to top

 

 

 

History and Physical Exam

A thorough history and physical can help diagnose pneumonia and also distinguish among different pathogens.

 

  • history
  • physical exam

History

Respiratory symptoms of pneumonia include:

  • cough
    • persistent, hacking - Mycoplasma
  • sputum production
  • dyspnea (shortness of breath)
  • chest pain, especially pleuritic
  • fever
  • malaise
  • absence of rhinorrhea or sore throat

A history of rhinitis or pharyngitis suggests respiratory virus, Mycoplasma, or Chlamydia. Abrupt onset of myalgia, arthralgia, headache, and fever are commonly seen in influenza virus infection.

 

Abrupt onset of myalgias, arthralgia, headache, and fever suggest influenza or mycoplasma.

 

Duration of symptoms is a critical piece of information:

  • pneumococcal, mycoplasma, or virual or viral disease is usually acute, with symptoms lasting for hours or days.
  • Symptoms lasting 10 days or longer are rarely caused by common bacterial pathogens and should raise suspicion of mycobacterium, fungal, or anaerobic pneumonia, and/or the presence of underlying disease.

Review of symptoms

  • diarrhea - suggests Legionella
  • altered mental status - ?meningitis

 

past medical history

  • asthma
  • dementia
  • immunosupression

Physical Exam

Most people with pneumonia have cough, fever, pleuritic chest pain, foul sputum, tachycardia, and tachypnea.

Tuberculosis can lead to high fever with few other symptoms.

Foul breath suggests anaerobes and/or lung abscess.

Confusion should immediately point to meningeal complications, or can simply represent delirium in the elderly.

Brown currant jelly sputum suggests Klebsiella

The respiratory exam can show evidence of consolidation via the following:

  • percussion dullness
  • bronchial breath sounds
  • crackles
  • increased fremitus
  • whispered pectoriloquy

Increasing tachypnea, cyanosis, and use of accessory muscles for respiration suggests serious illness. Foul breath suggests anaerobic infection, ie lung abscess.

 

If a person presents with abrupt onset of chills, cough, pleuritic chest pain, rusty or yellow sputum, and shortness of breath, and exam shows tachypnea shows even miminal signs of pulmonary inflammation, presumptive diagnosis of bacterial pneumonia should be made, sputum should be examined, and apropriate therapy should be begun.

 

Emperic therapy without sputum examination is often successful, but increases in antibiotic resistance and occasional misdiagnosis, leading to increased risk of morbidity and death, mean that sputum should be Gram-stained and examined immediately.

 

Diagnosis is made in about 20% of patients.

return to top

 

 

 

Investigations

  • lab investigations
  • diagnostic imaging

Lab Investigations

 

blood tests

  • CBCD: usual elevated white cell count, with left shift; higher for bacterial infection
  • lytes
  • urea, sCR
  • troponin/CK
  • AST, ALT, ALP,
  • bili: modest increases in conjugated bilirubin are seen in many bacterial infections
  • C-reactive protein: monitoring severity of infection and treatment response
  • blood culture: will be positive for 20-30% of people with bacterial pneumonia.

 

nasopharyngeal swab: influenza, parainfluenza, metapneumovirus, RSV, adenovirus

 

sputum smear and culture: must be done carefully to avoid contamination by oropharyngeal flora. Both false negatives and false positives are common and should be interpreted carefully.

  • gram stains
  • Gomori's Methenamine Silver (GMS stain)
  • PAS/diastase stain
  • Ziehl-Neelsen stain for mycobacteria: should be done unless diagnosis of acute bacterial pneumonia is clear
  • viral inclusions

 

 

other tests:

  • urinalysis
  • tuberculin skin test
  • lumbar puncture should be done in patients with penumonia and confusion to rule out meningitis
  • mycoplasma IgM
  • tissue biopsy can be very helpful, but its invasiveness is an important consideration.

Diagnostic Imaging

Suspect pneumonia in children with fever, cough, retractions, and tachypnea; a chest X-ray is not necessary in the outpatient setting (Harris et al, 2011).

 

chest X ray

Chest X-rays need to be examined in the context of clinical data to successfully lead to diagnosis. A negative chest X ray can never rule out acute pneumonia if signs and symptoms are strongly suggestive.

 

Hypersensitivity pneumonia, early milliary TB, or early PJP can result in symptoms in the absence of radiographic findings.

 

Findings on a chest X ray can include:

  • homogenous parenchymal consolidation involving one or more lobe
  • pleural effusions (S. pneumoniae or M. tuberculosis)
  • bilateral infiltration (Mycoplasma)
  • cavitation: suggests necrosis (TB, Staph, GNRs, anaerobes, fungi, or Pneumocystis jirovecci)

Radiologic findings of lobar pneumonias slowly clear, suggesting 6 week interval for followup.

return to top

 

 

 

Differential Diagnosis

The differential diagnosis of pneumonia includes:

return to top

 

 

 

Treatments

  • immediate
  • community-acquired
  • nosocomial
  • nursing home

Immediate Treatments

As with any patient, it is important to begin by treating the vitals, or ABCs, of the patient. This includes, as necessary:

  • oxygen administration and monitoring of saturation
  • positioning
  • IV access
  • salbutamol/Ventolin

Community-acquired Pneumonia

external resources:

Empiric treatment of CAP is often successful, but using broad-spectrum antibiotics can lead to increased resistance and occasional misdiagnosis.

The Americal Academy of Emergency Physicians now recommends against routine blood cultures and early antiobiotics for presumptive CAP, before definitive clinical diagnosis is made (Nazarian et al, 2009).

 

Previously healthy

No antibiotics within past three months:

  • amoxicillin/penicillin
  • macrolide (though resistance increasing)
  • doxycyline
  • fluoroquinolone

 

antibiotics with past three months:

  • fluoroquinolone
  • macrolide plus amoxocillin
  • macrolide plus amoxocillin-clavulin

 

co-morbidities (COPD, diabetes, renal failure, CHF, malignancy)

no antibiotics within past three months:

  • macrolide
  • fluoroquinolone

antibiotics within 3 months:

  • fluoroquinolone
  • macrolide plus beta-lactam

 

suspected aspiration (oral anaerobes)

  • amoxocillin-clavulanate
  • clindamycin

 

A small study has recommended the addition of dexamethasone to the treatment of hospitalized patients, as this appears to decrease length of stay (Meijvis et al, 2011).

Nosocomial Pneumonia

Patients who develop pneumonia from a health care setitng are at risk from a more dangerous pathogen, as described above. Antibiotics should be given according to likely pathogens involved:

 

Pseudomonas

  • ceftazedime
  • piperacillin-tazobactam

MRSA:

further gram -ve coverage

  • ciprofloxacin
  • aminoglycoside (gentamicin, tobramycin) plus fluroquinolone
  • aminoglycoside (gentamicin, tobramycin) plus macrolide (azithromycin)

suspect aspiration (oral anerobes)

  • clindamycin
  • metronidazole

 

ventilator-associated pneumonia

  • vancomycin/linezolid + ciprofloxacin/ceftazidime
  • cefepime and gentamycin
  • meropenem

Nursing Homes

 

For hospitalized patients, length of stay has been shown (Carratala et al, 2012) to be minimized by a clinical pathway prompting:

return to top

 

 

 

Consequences and Course

Complications of pneumonia include:

Prognosis can be predicted with scoring tools, such as the Pneumonia Severity Index (PSI) and the CURB-65 and CRB-65. All three appear to be similarly accurate (Ochoa-Gondar O et al, 2011).

Increased mortality occurs in patients with:

return to top

 

 

 

 

Resources and References

Carratala J et al. 2012. Effect of a 3-Step Critical Pathway to Reduce Duration of Intravenous Antibiotic Therapy and Length of Stay in Community-Acquired Pneumonia: A Randomized Controlled TrialA 3-Step Critical Pathway for CAP. Arch Intern Med. 172(12):922-8.

Harris J et al. 2010. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 66 Suppl 2:ii1-23.

Jung YJ, et al. 2010. Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia. Crit Care Med ;38(1):175-180.

 

Meijvis SC et al. 2011. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia. Lancet 377(9782):2023-2030.

 

Nazarian et al. 2009. Clinical policy: Critical issues in the management of adult patients presenting to the emergency department with community-acquired pneumonia. Ann Emerg Med. 54(5):704-731.

 

Ochoa-Gondar O et al. 2011. Comparison of three predictive rules for assessing severity in elderly patients with CAP. Int J Clin Pract. 65(11):1165-72.